Predictive Significance of p53, Ki-67, and Bcl-2 Expression for Pathologic Complete Response after Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer

PURPOSE: Patients with triple-negative breast cancer (TNBC) with pathologic complete response (pCR) to neoadjuvant chemotherapy (NAC) have superior survival outcomes compared to those with residual disease after NAC. This study investigated the value of three biomarkers, p53, Ki-67, and Bcl-2 for pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Taeryung, Han, Wonshik, Kim, Min Kyoon, Lee, Jun Woo, Kim, Jisun, Ahn, Soo Kyung, Lee, Han-Byoel, Moon, Hyeong-Gon, Lee, Kyung-Hun, Kim, Tae-Yong, Han, Sae-Won, Im, Seock-Ah, Park, In Ae, Kim, Ju-Yeon, Noh, Dong-Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381118/
https://www.ncbi.nlm.nih.gov/pubmed/25834606
http://dx.doi.org/10.4048/jbc.2015.18.1.16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381118/
https://www.ncbi.nlm.nih.gov/pubmed/25834606
http://dx.doi.org/10.4048/jbc.2015.18.1.16

Ejemplares similares